An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines, Blood & Biologics

DENGVAXIA

STN: 125682
Proper Name: Dengue Tetravalent Vaccine, Live
Tradename: DENGVAXIA
Manufacturer: Sanofi Pasteur, Inc.
Indication:

For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 6 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.

Product Information

Package Insert - DENGVAXIA
Demographic Subgroup Information – DENGVAXIA (Dengue Tetravalent Vaccine, Live)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top